Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion...
Saved in:
| Main Authors: | José E. Belizário, Joel Faintuch, Miguel Garay-Malpartida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/2037838 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
by: Jiani Li, et al.
Published: (2025-03-01) -
The gut-lung axis and microbiome dysbiosis in non-tuberculous mycobacterial infections: immune mechanisms, clinical implications, and therapeutic frontiers
by: Fangfang Zhu, et al.
Published: (2025-06-01) -
Gut microbiome dysbiosis as a potential biomarker for liver metabolic disorders in in neonatal hemolytic jaundice
by: Jin Huang, et al.
Published: (2025-04-01) -
Tropical infections and the gut microbiome: dysbiosis, recovery, and clinical implications
by: Biruk Demisse Ayalew, et al.
Published: (2025-08-01) -
Bridging Microbiomes: Exploring Oral and Gut Microbiomes in Autoimmune Thyroid Diseases- New Insights and Therapeutic Frontiers
by: Daliya Abubakar, et al.
Published: (2025-12-01)